Top Industry Leaders in the Aortic Valve Market
Latest Aortic Valve Companies Update:
Edwards Lifesciences (US) Launched their SAPIEN 3 Ultra RESILIA valve, incorporating breakthrough tissue technology for enhanced durability and performance. Received FDA approval for their TAVR system to treat patients with moderate aortic stenosis using a transapical approach.
Medtronic (Ireland) Expanded their TAVR portfolio with the Evolut™ R system, featuring a redesigned delivery system and improved valve positioning capabilities. Entered into a strategic partnership with Abbott to develop and commercialize new transcatheter heart valve technologies.
Abbott Laboratories (US) Received FDA approval for their TAVR system with a smaller delivery catheter, increasing its applicability to patients with challenging anatomies. Partnered with Medtronic to leverage expertise and accelerate innovation in the TAVR market.
Boston Scientific (US)Received CE Mark approval for their Lotus Edge™ TAVR system, offering a unique balloon-expandable platform with potentially reduced procedural complexity. Focused on expanding their global reach and market share for their TAVR systems.
List of Aortic Valve Key companies in the market
- Boston Scientific Corporation
- Medtronic
- Abbott Laboratories
- LivaNova PLC
- Edwards Lifesciences Corporation
- CryoLife
- Biotronik
- Colibri Heart Valve
- JenaValve
- TTK HealthCare